Quantbot Technologies LP Standard Biotools Inc. Transaction History

Quantbot Technologies LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.65 - $2.92 $23,850 - $42,208	14,455 New	14,455 $25,000
Q4 2021 Feb 11, 2022	SELL	$3.63 - $6.13 $11,499 - $19,419	-3,168 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$5.5 - $7.41 $17,424 - $23,474	3,168 New	3,168 $20,000
Q1 2021 May 14, 2021	SELL	$3.94 - $7.09 $268,239 - $482,694	-68,081 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$5.45 - $8.65 $371,041 - $588,900	68,081 New	68,081 $408,000
Q1 2020 May 13, 2020	SELL	$1.24 - $4.35 $1,743 - $6,116	-1,406 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$2.3 - $5.12 $27,254 - $60,672	-11,850 Reduced 89.39%	1,406 $4,000
Q3 2019 Nov 12, 2019	BUY	$4.63 - $12.15 $41,591 - $109,143	8,983 Added 210.23%	13,256 $61,000
Q2 2019 Aug 13, 2019	SELL	$11.49 - $14.17 $265,304 - $327,185	-23,090 Reduced 84.38%	4,273 $52,000
Q1 2019 May 13, 2019	BUY	$8.47 - $14.36 $231,764 - $392,932	27,363 New	27,363 $363,000

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $132M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.